- Home
- SDHC vs CDNA Comparison
SDHC vs CDNA Comparison
Compare SDHC & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDHC
- CDNA
- Stock Information
- Founded
- SDHC 2008
- CDNA 1998
- Country
- SDHC United States
- CDNA United States
- Employees
- SDHC N/A
- CDNA N/A
- Industry
- SDHC
- CDNA Medical Specialities
- Sector
- SDHC
- CDNA Health Care
- Exchange
- SDHC Nasdaq
- CDNA Nasdaq
- Market Cap
- SDHC 933.4M
- CDNA 844.7M
- IPO Year
- SDHC 2024
- CDNA 2014
- Fundamental
- Price
- SDHC $18.78
- CDNA $16.99
- Analyst Decision
- SDHC Hold
- CDNA Buy
- Analyst Count
- SDHC 4
- CDNA 6
- Target Price
- SDHC $23.63
- CDNA $30.33
- AVG Volume (30 Days)
- SDHC 53.9K
- CDNA 1.4M
- Earning Date
- SDHC 05-14-2025
- CDNA 04-30-2025
- Dividend Yield
- SDHC N/A
- CDNA N/A
- EPS Growth
- SDHC N/A
- CDNA N/A
- EPS
- SDHC 0.24
- CDNA 1.07
- Revenue
- SDHC $1,010,976,000.00
- CDNA $346,421,000.00
- Revenue This Year
- SDHC $6.51
- CDNA $13.38
- Revenue Next Year
- SDHC $11.93
- CDNA $15.33
- P/E Ratio
- SDHC $79.78
- CDNA $15.49
- Revenue Growth
- SDHC 28.67
- CDNA 25.92
- 52 Week Low
- SDHC $16.28
- CDNA $12.90
- 52 Week High
- SDHC $39.50
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- SDHC 50.39
- CDNA 49.78
- Support Level
- SDHC $16.28
- CDNA $16.57
- Resistance Level
- SDHC $18.45
- CDNA $18.02
- Average True Range (ATR)
- SDHC 1.18
- CDNA 0.77
- MACD
- SDHC 0.05
- CDNA 0.14
- Stochastic Oscillator
- SDHC 52.14
- CDNA 59.45
About SDHC Smith Douglas Homes Corp.
Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. It is organized into eight geographical divisions which comprise two reportable segments. Its Southeast segment consists of Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of Alabama, Houston, and Nashville divisions.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.